BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15359828)

  • 1. [Differential diagnosis between asymptomatic HCV carriers and previously infected patients with anti-HCV antibody in general clinic setting].
    Yasuda K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):391-5. PubMed ID: 15359828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early diagnosis of acute hepatitis C--detection of anti-HCV antibody and HCV-RNA].
    Yoshizawa K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):353-6. PubMed ID: 15359820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N; Us T; Akgün Y
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of hepatitis C virus nucleic acid testing among antibody-reactive or confirmed-positive samples.
    Schmidt M; Weber M; Busch MP; Tobler LH; Phelps BH; Seifried E; Roth WK
    Transfusion; 2005 Jun; 45(6):1040-2. PubMed ID: 15935008
    [No Abstract]   [Full Text] [Related]  

  • 5. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
    Dussol B; de Lamballerie X; Brunet P; Roubicek C; Chicheportiche C; Cantaloube JF; Biagini P; de Micco P; Berland Y
    Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic tests: Hepatitis C virus genome (HCV RNA)].
    Tanaka T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():415-7. PubMed ID: 16111289
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features.
    Stefanidis I; Liakopoulos V; Rigopoulou EI; Dalekos GN
    Am J Kidney Dis; 2005 Nov; 46(5):992-3; author reply 993. PubMed ID: 16253745
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current aspects of hepatitis C diagnosis].
    Echevarría JM; León P
    Enferm Infecc Microbiol Clin; 1995; 13(7):387-9. PubMed ID: 8519814
    [No Abstract]   [Full Text] [Related]  

  • 13. [The present state and problems of HCV blood screening system in blood products].
    Yatsuhashi H; Yano M
    Nihon Rinsho; 2001 Jul; 59(7):1303-7. PubMed ID: 11494542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
    Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for viral persistence in patients who test positive for anti-hepatitis C virus antibodies and have normal alanine aminotransferase levels.
    Radkowski M; Horban A; Gallegos-Orozco JF; Pawelczyk A; Jablonska J; Wilkinson J; Adair D; Laskus T
    J Infect Dis; 2005 May; 191(10):1730-3. PubMed ID: 15838801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in French hemodialysis units: a multicenter study.
    Salama G; Rostaing L; Sandres K; Izopet J
    J Med Virol; 2000 May; 61(1):44-51. PubMed ID: 10745231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
    Wiesner RH
    Hepatology; 2008 Dec; 48(6):1734-6. PubMed ID: 19026008
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
    Kanno A; Kazuyama Y
    J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.